Description
A potent GPR39 agonist (EC50s = 0.8 and 0.4 nM for cAMP production in HEK293 cells expressing human and rat receptors, respectively); selective for GPR39 over a panel of kinases (IC50s = >10 μM), ghrelin and neurotensin-1 receptors (IC50s = >30 μM), and a variety of enzymes, transporters, or G protein-coupled receptors; increases secretion of GLP-1 in STC-1 cells (EC50 = 0.06 μM); is protective against cytokine-induced cell death in INS-1E cells (EC50 = 0.02 μM); increases the amount of active GLP-1 in sera in glucose-challenged mice when administered concurrently with a DPP-4 inhibitor at 30 mg/kg,
Formal name: N-[3-chloro-4-[[[2-(methylamino)-6-(2-pyridinyl)-4-pyrimidinyl]amino]methyl]phenyl]-methanesulfonamide
Synonyms:
Molecular weight: 418.9
CAS: 1621175-65-2
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes